Actualizaciones regulatorias
Novedades regulatorias de FDA, EMA, TGA y organismos globales
#Actavis Pharma ×
Actualizaciones regulatorias
17 sept 2026•1 min de lectura
FDA Approves Griseofulvin Oral Suspension (ANDA 065394)
The FDA has approved an oral suspension of griseofulvin (125 mg/5 mL) from Actavis Pharma under ANDA 065394.
1
Actualizaciones regulatorias
30 ago 2026•1 min de lectura
FDA Approves Levetiracetam Oral Solution (ANDA078976)
FDA has approved ANDA078976 for Levetiracetam oral solution, a prescription drug manufactured by Actavis Pharma, Inc., with a detailed submission history.